|
|
|
|
|
by epmaybe
2097 days ago
|
|
I would like to point out the limitations of the linked paper (you can follow along in the discussion section of the paper). Hopefully this can generate enough discussion on how to better design studies like this in the future: 1. Statistically significant difference in patients with documented hypertension in the no-vitamin-d group (p value 0.002, 15 vs 11 patients) 2. 2:1 randomization, reducing statistical power. They do not document the sample size needed from a power analysis looking for power > 0.80. They basically assumed that twice as many people without vitamin D would end up in ICU, when in reality 13x as many people ended up ICU. In general, I wish we could have a larger sample size for studies like this, but I know it isn't practical. 3. Biggest for me is no baseline serum vitamin D level recorded, just an assumption that patients selected were overall vitamin D deficient based on population. Seems like a simple enough test that could have been run as a send out test (no need to have the level during hospitalization, just for data gathering purposes). 4. Not placebo controlled, would have helped as placebo effect is real. For all we know, giving the research medication could have meant that the patient received more care and supervision, potentially aiding in their hospital course. |
|